Oxidative stress, and iron and antioxidant status in elderly men: Differences between the Mediterranean south (Crete) and northern Europe (Zutphen)

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 14, Issue 4, 2007, Pages 495-500

  Buijsse, Brian ^a,b   Feskens, Edith J ^a,b   Moschandreas, Joanna ^c   Jansen, Eugène H ^a   Jacobs Jr , David R ^d,e   Kafatos, Anthony ^c   Kok, Frans J ^b   Kromhout, Daan ^a,b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF CRETE   (Greece)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Antioxidants; Iron status; Oxidative stress

Indexed keywords

ALBUMIN; ANTIOXIDANT; BILIRUBIN; C REACTIVE PROTEIN; CAROTENOID; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROPEROXIDE; IRON; LYCOPENE; TOCOPHEROL; URIC ACID; VITAMIN;

AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; DISEASE MARKER; ELDERLY CARE; GEOGRAPHIC DISTRIBUTION; GREECE; HUMAN; IRON BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SOUTHERN EUROPE;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BIOLOGICAL MARKERS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; GREECE; HUMANS; IRON; MALE; NETHERLANDS; OXIDATIVE STRESS; RISK FACTORS;

EID: 34547754949     PISSN: 17418267     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3280111e41     Document Type: Article

References (26)

1. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11:298-300.
2. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408:239-247.
3. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine, 2nd ed. New York, USA: Oxford University Press; 1985. pp. 416-494.
4. Johnson MA, Fischer JG, Bowman BA, Gunter EW. Iron nutriture in elderly individuals. FASEB J 1994; 8:609-621.
5. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86:803-811.
6. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997; 18:1231-1248.
7. Kesteloot H, Sans S, Kromhout D. Evolution of all-causes and cardiovascular mortality in the age-group 75-84 years in Europe during the period 1970-1996; a comparison with worldwide changes. Eur Heart J 2002; 23:384-398.
8. Kromhout D, Menotti A, Blackburn H, (eds). Prevention of coronary heart disease: diet, lifestyle and risk factors in the Seven Countries Study. Norwell, MA, USA: Kluwer Academic Press; 2002.
9. Keys A, Aravanis C, Blackburn HW, van Buchem FSP, Buzina R, Djordjevic BS, et al. Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand 1966; 460 (Suppl.):1-392.
10. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38:535-539.
11. Heath AL, Fairweather-Tait SJ. Health implications of iron overload: the role of diet and genotype. Nutr Rev 2003; 61:45-62.
12. Bijnen FC, Caspersen CJ, Feskens EJ, Saris WH, Mosterd WL, Kromhout D. Physical activity and 10-year mortality from cardiovascular diseases and all causes: the Zutphen Elderly Study. Arch Intern Med 1998; 158:1499-1505.
13. Griffiths HR, Moller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, et al. Biomarkers. Mol Aspects Med 2002; 23:101-208.
14. Miura K, Nakagawa H, Nakamura H, Tabata M, Nagase H, Yoshida M, Kawano S. Serum gamma-glutamyl transferase level in predicting hypertension among male drinkers. J Hum Hypertens 1994; 8:445-449.
15. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49:1358-1366.
16. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998; 21:732-737.
17. Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000;31:1851-1855.
18. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005; 112:2130-2137.
19. Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, et al. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 2004; 109:1440.
20. Danesh J, Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 1999; 99:852-854.
21. Sempos CT, Looker AC, Gillum RF, McGee DL, Vuong CV, Johnson CL. Serum ferritin and death from all causes and cardiovascular disease. The NHANES II Mortality Study. Ann Epidemiol 2000; 10:441-448.
22. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation 2001; 103:52-57.
23. Parker RS. Absorption, metabolism, and transport of carotenoids. FASEB J 1996; 10:542-551.
24. Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002; 105:22-26.
25. Doshi SN, McDowell IF, Moat SJ, Lang D, Newcombe RG, Kredan MB, et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol 2001; 21:1196-1202.
26. Williams C, Kingwell BA, Burke K, McPherson J, Dart AM. Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype. Am J Clin Nutr 2005; 82:26-31.